Holen Sie sich die Stockscreener-App
5.74
4.97%
-0.30
Schlusskurs vom Vortag:
$6.04
Offen:
$5.95
24-Stunden-Volumen:
57,488
Relative Volume:
0.24
Marktkapitalisierung:
$357.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-76.41M
KGV:
-2.9896
EPS:
-1.92
Netto-Cashflow:
$-64.56M
1W Leistung:
-9.89%
1M Leistung:
-5.12%
6M Leistung:
-6.67%
1J Leistung:
-43.56%
1-Tages-Spanne:
$5.75
$5.96
1-Wochen-Bereich:
$5.75
$6.47
52-Wochen-Spanne:
$4.345
$11.29
Aura Biosciences Inc Stock (AURA) Company Profile
Firmenname
Aura Biosciences Inc
Sektor
Branche
Telefon
(617)500-8864
Adresse
80 GUEST STREET, BOSTON
Vergleichen Sie AURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
5.76 | 375.20M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.64 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.61 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.19 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
843.71 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.89 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-04-17 | Fortgesetzt | BTIG Research | Buy |
| 2022-07-19 | Eingeleitet | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Aktie (AURA) Neueste Nachrichten
Published on: 2025-11-04 00:27:04 - newser.com
How analysts rate Aura Biosciences Inc. stock todayQuarterly Earnings Summary & Reliable Momentum Entry Alerts - newser.com
Volume spikes in Aura Biosciences Inc. stock – what they mean2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
What drives Aura Biosciences Inc stock priceDouble Top/Bottom Patterns & Free Superior Stock Performance - earlytimes.in
Is it time to cut losses on Aura Biosciences Inc.Oil Prices & Smart Swing Trading Alerts - newser.com
Is Aura Biosciences Inc. stock cheap compared to fundamentalsWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com
Real time pattern detection on Aura Biosciences Inc. stockTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
How Aura Biosciences Inc. stock performs after earningsMarket Risk Report & Daily Growth Stock Tips - newser.com
Can you recover from losses in Aura Biosciences Inc.July 2025 Spike Watch & Safe Entry Point Identification - newser.com
Applying big data sentiment scoring on Aura Biosciences Inc.Market Risk Report & Reliable Entry Point Trade Alerts - newser.com
How Aura Biosciences Inc. stock performs in weak economyWeekly Trade Recap & Fast Gain Swing Alerts - newser.com
Should you hold or exit Aura Biosciences Inc. nowJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
How to build a dashboard for Aura Biosciences Inc. stockOptions Play & Long-Term Investment Growth Plans - newser.com
Aura Biosciences Inc. stock outlook for YEAR2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Aura Biosciences CEO Makes Significant Stock Sale! - TipRanks
Aura Biosciences Director Elisabet de los Pinos Sells Shares to Cover Tax Obligations - TradingView
Form 4: AURA officer automatic sale of 896 shares to cover taxes - Stock Titan
AURA insider sale: 9,049 shares at $6.35 for RSU withholding - Stock Titan
Aura Biosciences’ Phase 3 Trial: A Potential Game-Changer in Ocular Melanoma Treatment - TipRanks
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Is Aura Biosciences Inc. stock trading near support levelsEarnings Trend Report & Safe Swing Trade Setups - Fundação Cultural do Pará
Aura Biosciences Advances Bladder Cancer Treatment with AU-011 Study - TipRanks
Aura Biosciences Advances Eye Cancer Treatment with Phase 2 Trial Update - TipRanks
Published on: 2025-10-27 06:14:42 - newser.com
Finanzdaten der Aura Biosciences Inc-Aktie (AURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):